Medtronic plc logo
Medtronic plc (MDT)
Compare

MDT Income Statement

Revenue, expenses, and profitability analysis

MDT Quarterly Income Statement (USD)

Quarterly ReportTTM
04/24/2026
01/23/2026
10/24/2025
07/25/2025
04/30/2025
04/25/2025
01/24/2025
10/25/2024
23.643B7.441B5.851B5.405B4.946B5.780B5.513B5.457B
36.364B9.807B9.018B8.961B8.578B8.927B8.292B8.403B
Cost of Goods Sold
12.721B2.367B3.166B3.556B3.632B3.147B2.779B2.946B
75.9%75.9%64.9%60.3%57.7%64.7%66.5%64.9%
Total Operating Expenses
17.179B5.880B4.078B3.720B3.501B4.344B3.867B3.862B
2.873B671.000M722.000M754.000M726.000M684.000M675.000M697.000M
11.784B3.057B2.955B2.966B2.806B2.720B2.717B2.757B
6.467B1.564B1.773B1.685B1.445B1.436B1.646B1.595B
15.9%15.9%19.7%18.8%16.8%16.1%19.9%19.0%
6.136B1.834B1.404B1.596B1.302B1.261B1.540B1.559B
Interest Income
-154.000M121.000M33.000M
715.000M177.000M181.000M181.000M176.000M174.000M179.000M209.000M
Other Income/Expense
-331.000M270.000M-369.000M-89.000M-143.000M-175.000M-106.000M-36.000M
4.800B1.243B1.143B1.374B1.040B1.057B1.294B1.270B
1.299B575.000M254.000M215.000M255.000M199.000M237.000M281.000M
12.7%12.7%12.7%15.3%12.1%11.8%15.6%15.1%
9.093B2.012B2.490B2.366B2.225B2.275B2.403B2.443B
EBITDA Margin
20.5%20.5%27.6%26.4%25.9%25.5%29.0%29.1%
2.242B0.00905.000M589.000M748.000M840.000M684.000M675.000M
EPS Basic
3.750.980.891.070.810.821.010.99
3.730.960.891.070.810.821.010.99
Shares Outstanding
1.282B1.282B1.282B1.282B1.282B1.282B1.282B1.282B
Diluted Shares Outstanding
1.288B1.288B1.288B1.288B1.287B1.288B1.286B1.287B

MDT Annual Income Statement (USD)

Annual Report
04/24/2026
04/30/2025
04/25/2025
04/30/2024
04/26/2024
04/30/2023
04/28/2023
04/30/2022
23.643B21.905B21.148B20.508B21.541B
36.364B33.537B32.364B31.227B31.686B
Cost of Goods Sold
12.721B11.632B11.216B10.719B10.145B
65.0%65.3%65.3%65.7%68.0%
Total Operating Expenses
17.179B15.950B16.004B15.023B15.789B
2.873B2.732B2.735B2.696B2.746B
11.784B10.849B10.736B10.415B10.292B
6.467B5.955B5.144B5.485B5.752B
17.8%17.8%15.9%17.6%18.2%
6.136B5.628B4.837B5.364B5.517B
Interest Income
715.000M729.000M719.000M636.000M553.000M
Other Income/Expense
-331.000M-327.000M-307.000M-121.000M-235.000M
4.800B4.662B3.676B3.758B5.039B
1.299B936.000M1.133B1.580B456.000M
13.2%13.9%11.4%12.0%15.9%
6.851B9.218B8.203B8.697B8.777B
EBITDA Margin
18.8%27.5%25.3%27.9%27.7%
0.002.861B2.647B2.697B2.707B
EPS Basic
3.753.632.772.833.75
3.733.612.762.823.73
Shares Outstanding
1.282B1.286B1.328B1.330B1.342B
Diluted Shares Outstanding
1.288B1.290B1.330B1.333B1.351B

Values are displayed in USD. Negative numbers shown in red.

Values are displayed in USD. Negative numbers are shown in red.

About Medtronic plc

Medtronic plc is a leading global medical technology enterprise that invents, develops, manufactures, and distributes an extensive range of device-based medical therapies. These solutions serve healthcare systems, clinicians, physicians, and patients across the world. The company's operations are categorized into several key portfolios: Cardiovascular Portfolio: This segment focuses on cardiac health, providing technologies for heart rhythm management, including implantable pacemakers, defibrillators, and monitoring systems, alongside cardiac ablation tools and remote patient software. It also addresses structural heart issues with products like aortic and pulmonary valves, surgical repair devices, and endovascular stent grafts, in addition to offerings for percutaneous coronary interventions (e.g., angioplasty balloons). Medical Surgical Portfolio: Offering a broad spectrum of surgical instruments and therapies, this division includes staples, vessel sealing devices, wound closure products, and electrosurgical equipment. It also pioneers surgical artificial intelligence and robotic-assisted platforms, alongside solutions for hernia repair, gynecology, lung conditions, minimally invasive gastrointestinal and hepatologic diagnostics, patient monitoring, airway management, ventilation therapies, and renal disease. Neuroscience Portfolio: This division delivers specialized products for a diverse group of medical professionals, such as spinal surgeons, neurosurgeons, neurologists, pain management specialists, and ENT experts. Its offerings span energy surgical instruments, advanced image-guided and intra-operative imaging systems, robotic guidance for spine procedures, and therapies targeting the brain's vasculature. Diabetes Operating Unit: Dedicated to diabetes management, this unit provides innovative solutions like insulin pumps and their associated consumables, continuous glucose monitoring (CGM) systems, and smart insulin pen technologies. Established in 1949, Medtronic plc maintains its corporate headquarters in Dublin, Ireland.

Galway
95,000 employees
Healthcare / Medical - Devices
Sector
Healthcare
Industry
Medical - Devices
CEO
Geoffrey Straub Martha